Biogenic Amines and Psychiatry

Ashcroft G. W. Eccleston D. Knight F. MacDougall E. J. Waddell J. C. (1965). Changes in amine metabolism produced by antidepressant drugs. J. psychosom. Res., 9: 129.

Brodie B. B. Pletscher A. Shore P. A. (1955). Evidence that serotonin has a role in brain function. Science, 122: 968.

Brodie B. B. Reid W. D. (1968). Serotonin in brain; functional considerations. In Garattini S. Shore P. A. (Eds.): Recent Advances in Pharmacology, Vol 6. Academic Press, New York.

Brodie B. B. Shore P. A. (1957). A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann. N.Y. Acad. Sc., 66: 631.

Carlsson A. (1966). Drugs which block the storage of 5-HT and related amines. In Eichler O. Farah A. (Eds.) Handbuch der Experimentellen Pharmakologie, Vol. XIX, 5-Hydroxy-Tryptamine and related Indolealkylamines. Springer-Verlag, Berlin.

Carlsson A. (1968). In Garattini S. Shore P. A. (Eds.) Recent Advances in Pharmacology, Vol. 6. Academic Press, New York.

Coppen A. J. (1968). Biogenic amine theory of depression. In Garattini S. Shore P. A. (Eds.) Recent Advances in Pharmacology, Vol 6. Academic Press, New York.

Coppen A. J. (1967). Biochemistry of affective disorders. In New Trends in Psychopharmacology. Excerpta Medica Foundation, I.C.S. No. 150.

Cytryn L. Lourie R. S. (1967). Mental Retardation. In Freedman A.M. Kaplan R.I. Comprehensive Textbook of Psychiatry. Williams and Wilkins, Baltimore.

Dewhurst W. C. (1968a). Methysergide in the treatment of mania. Lancet. 1: 1369.

Dewhurst W. G. (1968b). New theory of central amine function and its clinical application. Nature 218: 1130.

Dewhurst W. G. (1970). Amines and abnormal mood. Proc. roy. Soc. Med., 62: 1102.

Dixit B. N. Buckley J. P. (1967). Circadian changes in brain 5-HT and plasma corticosterone in the rat. Life Sciences, Pt. 1, Vol. 6, No. 7.

Doyle A. E. Smirk F. H. (1954). Hypotensive action of reserpine. Lancet, 1: 1096.

Ebadi M. S. Russell R. L. McCoy E. E. (1968). The inverse relationship between the activity of pyridoxal kinase and the level of biogenic amines in rabbit brain. J. Neurochem., 15; 659.

Fischer E. (1969). Recent investigations on a possible dysmetabolic endotoxic origin of schizophrenia. Behav. Neuropsychiat. 1: 21.

Friedhoff A. J. van Winkle E. (1962). The characteristics of an amine found in the urine of schizophrenic patients. J. nerv. ment. Dis., 135: 550.

Garattini S. Valzelli L. (1957). In Garattini S. Ghetti V. (Eels.) Psychotropic Drugs. Elsevier, Amsterdam.

Gellhorn E. (1965). The neurophysiological basis of anxiety: a hypothesis. Perspect. Biol. Med., 8: 488.

Haskovec I. Rysanek K. (1967). The action of reserpine in imipramine-resistant depressive states. Psycho-pharmacologia, 11: 18.

Heller B. Narasimhachar N. Spaide J. Haskovec L. Himwich N. E. (1970). N-dimethylated indoleamines in blood of acute schizophrenics. Experientia, 26: 503.

Himwich H. E. Brune G. Hohl H. (1963). Urinary excretion of bufotenine-like substance in psychotic patients. J. Neuropsychiat., 5: 14.

Hoffer A. Osmond H. Smythies J. (1954). Schizophrenia: a new approach, II. Result of a year's research. J. ment. Sc., 100: 29.

Jouvet M. (1968). Neuropharmacology of sleep. In Effron D. H. (Ed.): Psychopharmacology, a Review of Progress 1957–1967. Public Health Service Publications, No 1836, U.S.A.

Juorio A. V. Vogt M. (1967). Monoamines and their metabolites in the avian brain. J. Physiol., 189: 489.

Klerman G. L. Cole J. O. (1965). Clinical pharmacology of imipramine and related antidepressant compounds. Pharmacol. Rev., 17: 101.

Lemieux G. Davignon A. Genest J. (1956). Depressive states during rauwolfia therapy of arterial hypertension. Can. med. Assoc. J., 74: 522.

Leonard B. E. Tonge S. R. (1969). The effects of some hallucinogenic drugs upon the metabolism of NA. Life Sciences, Part I, 8: 815.

Lomax P. Foster R. S. Kirkpatrick W. E. (1969). Cholinergic and adrenergic interactions in the thermo-regulatory centres of the rat brain. Research, 15: 431.

Mandell A. J. Morgan M. (1970). Human brain enzyme makes indole hallucinogens. Paper read at A.P.A. Congress.

Marley E. (1968). Action of sympathomimetic and allied amines on the central nervous system. Scientific basis of medicine. Annual Reviews, Univ. of London.

Meister A. (1965). Biochemistry of the amino acids, Academic Press, New York. 2: 841.

McLeod W. R. (1970). Unpublished M.D. Thesis. University of Melbourne.

Oswald I. (1965). Biochemical functions involved in the control of sleep and dreaming: a summary. J. psychosom. Res., 9: 111.

Page I. H. (1968a). Serotonin. U.S.A. Year Book Medical Publishers Inc.

Page I. H. (1968b). Advances in pharmacology. In Garattini S. Shore P. A. (Eds.) Recent Advances in Pharmacology, Vol. 6A. Academic Press, New York.

Papez J. N. (1937). Arch. Neurol. Psychiat. 38: 725.

Pollin W. Gardon P. Kety S. S. (1961). Science 133: 104.

Quay W. B. (1968). Differences in circadian rhythms in 5-HT according to brain region. Amer. J. Physiol., 215: 448.

Smythies J. R. (1965). Psychiatric and biochemical aspects of Parkinsonism. J. psychosom. Res., 9: 103.

Tsuchiya K. Toru M. Kobayashi T. (1969). Sleep deprivation: changes of monoamines and acetyl choline in rat brain. Life Sciences, Part I, 8: 867.

Vogt M. (1968). Advances in pharmacology. In Garattini S. Shore P. A. (Eds.) Recent Advances in Pharmacology, Vol. 6B. Academic Press, New York.

Wender P. H. Epstein R. S. Kopin I. J. (1970). Brain dysfunction in children: urinary monoamines. Paper read at A.P.A. Congress.

Winston F. (1969). Oral contraceptives and depression. Lancet, 1: 1209.